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We thank Dr Medford1 for the
valuable additional analysis concern-
ing the cost benefits of cryobiopsy
based on our recently published article
in the Journal.2
We assume that routine use of a flex-
ible cryoprobe to obtain tissue samples
is cost-effective. However, it has to be
considered that cryobiopsies generally
require protected airways (ie, intuba-
tion). In addition, deep sedation using
midazolam or disoprivan, if not general
anesthesia, is required. In most coun-
tries, this makes additional personnel
or an additional physician (eventually
an anesthetist) necessary, which in
turn leads to an increase in costs. Fur-
ther, different health care systems
may have different tariffs for broncho-
scopic procedures, and this might cause
a variation in final cost-effectiveness
between different countries. Studies in-
vestigating the cost-effectiveness are
under way. Most likely, cryobiopsy is
a method that will result in cost savings
over time. In this sense, we absolutely
agree with Dr Medford.
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To the Editor:
We read with great interest the re-
cent article by Xydas and colleagues.1
In this study, they introduced a
novel technique using left carotid–
subclavian bypass (CSB) before arch
replacement with staged thoracic stent
grafting to achieve hybrid arch recon-
struction. Compared with the conven-
tional method, the major advantage of
this technique is using prepared CSB
to anastomose the left carotid artery
to the graft before cardiopulmonary
bypass (CPB). Only 2 anastomoses
(anastomoses of the distal graft to the
aorta and the graft to the innominate
artery) must be done during hypo-
thermic circulatory arrest (HCA),
decreasing selective antegrade cere-
bral perfusion (SACP), CPB and aor-
tic crossclamp times, and limiting
HCA.
Currently, HCA with SACP is
widely used as routine means to pro-
tect the central nervous system duringardiovascular Surgery c August 2010aortic arch replacement; however, to
some degree, the safe time of HCA
with SACP is limited. Therefore, the
best way to protect the brain and spinal
cord is to shorten the period of HCA as
much as possible. Even though the
technique of Xydas and associates1
mentioned in this article could reduce
the HCA time by using CSB to com-
plete the anastomosis of the left carotid
artery to the graft off CPB, we still
think a few questions and limitations
need to be considered when using
this method. First, the premise of using
CSB depends on the pathologic
changes of the arch without spreading
to the left subclavian artery. Second,
might the shunt of CSB lead to cere-
bral malperfusion during this short
term? Third, compared with the tech-
nique we used (total arch replacement
combined with stented elephant trunk
implantation, which we called the
‘‘Sun’s procedure’’ 2-4 Xydas’ method
still requires staged thoracic stent
grafting to achieve hybrid arch recon-
struction.
In our opinion, the Sun’s procedure
for arch reconstruction is more effi-
cient, simple, and safe. The Sun
procedure has been advocated and de-
veloped by our research group since
2003.5,6 Herein, we have summarized
the Sun’s surgical procedure and
made a comparison with the CBS pro-
cedure.
A stent graft (MicroPort Medical
Company Limited, Shanghai, China)
(Figure 1) and 4-branched prosthetic
graft (Meadox Hemashield Platinum
4 Branch Graft; Boston Scientific Inc,
Boston, Mass) were used in total arch
replacement combined with stented
elephant trunk implantation. Cannula-
tion of the right axillary artery was
used for CPB and SCP. The arterial
line was bifurcated for the right axil-
lary artery and for lower body perfu-
sion via 1 branch of a 4-branched
prosthetic graft. During cooling, the
proximal ascending aorta was opened
longitudinally, and aortic root proce-
dures could be done if necessary.
HCA was established when the target
